A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2011
12/29/2011	US20110319384 Pharmaceutical Compositions
12/29/2011	US20110319383 Extended Release Formulations Comprising Quetiapine and Methods for Their Manufacture
12/29/2011	US20110319381 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
12/29/2011	US20110319380 Compounds for Treating Disorders Mediated by Metabotropic Glutamate Receptor 5, and Methods of Use Thereof
12/29/2011	US20110319372 Method of diagnosing and therapeutically treating a patient for a traumatic brain injury
12/29/2011	US20110319367 Phenazopyridine Compounds
12/29/2011	US20110319352 Compounds That Bind Oxysterol Binding Proteins, and Methods of Use Thereof
12/29/2011	US20110319350 Glycoside compounds and pharmaceutical compositions thereof
12/29/2011	US20110319334 Compositions and methods for prevention and treatment of neurodegenerative diseases
12/29/2011	US20110319330 Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury
12/29/2011	US20110319329 Use of somatostatin analogs in cluster headache
12/29/2011	US20110319323 Pharmaceutical composition and method of use to improve organ function
12/29/2011	US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
12/29/2011	US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
12/29/2011	US20110318435 Composition comprising longan arillus extract or combined extract comprising the same for treating neurodegenerative disease
12/29/2011	US20110318431 Pharmaceutical Compositions and Methods of Treating Neurological Insults
12/29/2011	US20110318425 TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR, 10aR)- DELTA-8-TETRAHDRAOCANNABINOL-11-OIC ACIDS
12/29/2011	US20110318414 Regenerative tissue grafts and methods of making same
12/29/2011	US20110318412 Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
12/29/2011	US20110318393 Substituted Pyrazole Compounds
12/29/2011	US20110318392 Drug coating providing high drug loading and methods for providing the same
12/29/2011	US20110318388 S1P Receptors Modulators and Their Use Thereof
12/29/2011	US20110318381 Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction
12/29/2011	US20110318365 Methods for treatment of degenerative disease associated with apoptosis
12/29/2011	US20110318358 Immunotherapy for clearing pathological tau conformers
12/29/2011	US20110318346 Alpha B-crystallin as a therapy for Ischemia or inflammation
12/29/2011	US20110318345 Nasal delivery
12/29/2011	US20110318340 Deglycosylated antibodies
12/29/2011	US20110318329 Method of treatment or prophylaxis
12/29/2011	US20110318326 Compositions and Methods
12/29/2011	US20110318324 Methods and compositions for cns delivery of b-galactocerebrosidase
12/29/2011	US20110318323 Methods and compositions for cns delivery of iduronate-2-sulfatase
12/29/2011	US20110318318 Anti-apoptotic fusion proteins
12/29/2011	US20110318313 Modulation of Splenocytes in Cell Therapy for Traumatic Brain Injury
12/29/2011	US20110318310 Method for enhancing stem cell trafficking
12/29/2011	US20110318299 Composition for Accelerating Nerve Repair
12/29/2011	US20110318271 Arginase Inhibitors for the Treatment of Depression
12/29/2011	DE102010030538A1 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln 6,7-dihydro-5H-benzo [7] annulene derivatives, processes for their preparation, pharmaceutical compositions containing them, and their use for the preparation of medicaments
12/29/2011	CA2836445A1 Methods of treating optic disorders
12/29/2011	CA2803923A1 Methods of using sterculic acid
12/29/2011	CA2803258A1 Pharmaceutical composition comprising midazolam
12/29/2011	CA2803156A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors
12/29/2011	CA2803003A1 Methods and compositions for cns delivery of arylsulfatase a
12/29/2011	CA2802895A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors
12/29/2011	CA2802733A1 Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
12/29/2011	CA2802413A1 Use of an estrogen derivative for the manufacture of pharmaceutical compositions useful for the treatment and/or prevention of psychiatric diseases and for the treatment and prevention of said diseases
12/29/2011	CA2801818A1 Phosphate ester compound of hydroxy acid substituted phenol ester, preparation method and medical use thereof
12/29/2011	CA2801582A1 Hydroxy acid ester compound of substituted phenol, preparation method and medical use thereof
12/29/2011	CA2801458A1 Amido-tropane derivatives
12/29/2011	CA2801154A1 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof
12/29/2011	CA2800970A1 Use of 1h-quinazoline-2,4-diones
12/29/2011	CA2797874A1 Quinolizidine and indolizidine derivatives
12/29/2011	CA2792966A1 Anellated pyridine compounds as dual modulators of the 5-ht2a and d3 receptors
12/28/2011	EP2399930A1 N-terminally monopegylated polypeptides and process for their preparation
12/28/2011	EP2399926A1 Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents
12/28/2011	EP2399917A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
12/28/2011	EP2399910A1 Novel triazine derivative and pharmaceutical composition containing same
12/28/2011	EP2399903A1 Ccr9 inhibitors and methods of use thereof
12/28/2011	EP2399589A1 Hydrogel of polysaccharide derivatives
12/28/2011	EP2399577A1 Use of N-containing spirocompounds for the enhancement of cognitive function
12/28/2011	EP2399135A2 Method for inhibiting neurodegeneration
12/28/2011	EP2398810A1 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
12/28/2011	EP2398807A1 (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
12/28/2011	EP2398802A1 DERIVATIVES OF 6-CYCLOAMINO-2-THIENYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND 6-CYCLOAMINO-2-FURANYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE, PREPARATION AND THERAPEUTIC APPLICATION THEREOF
12/28/2011	EP2398795A1 Heteroaryl substituted pyridazinone derivatives
12/28/2011	EP2398793A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
12/28/2011	EP2398789A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
12/28/2011	EP2398783A1 Carboxamide compounds and their use as calpain inhibitors
12/28/2011	EP2398782A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
12/28/2011	EP2398780A1 Cyclopropyl amide derivatives targeting the histamine h3 receptor
12/28/2011	EP2398771A2 Heterocyclic compounds which modulate the cb2 receptor
12/28/2011	EP2398768A1 Pyrrolidine derivatives as nk3 receptor antagonists
12/28/2011	EP2398760A1 Allosteric binding compounds
12/28/2011	EP2398558A1 Amine or amino alcohols as glyt1 inhibitors
12/28/2011	EP2398500A2 Glutathione-based drug delivery system
12/28/2011	EP2398488A1 Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
12/28/2011	EP2398477A1 Methods of and compositions for reducing cell death
12/28/2011	EP2398475A1 Pharmaceutical preparation and delivery system
12/28/2011	EP2398471A2 Use of resveratrol or another hydroxylated stilbene for preserving cognitive functioning
12/28/2011	EP2398324A1 PYRAZOLO [4,3-c]CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
12/28/2011	EP2205560B1 Azabicyclo [3. 1. 0]hexyl derivatives as modulators of dopamine d3 receptors
12/28/2011	EP2200980B9 Amino arylsulfonamide compounds and their use as 5-ht6 ligands field of invention
12/28/2011	EP2197843B1 Piperidine derivatives as agonists of muscarinic receptors
12/28/2011	EP2132224B1 Cyclic receptor-associated protein (rap) peptides
12/28/2011	EP2077719B1 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
12/28/2011	EP1896025B1 Scopolamine for the treatment of depression and anxiety
12/28/2011	EP1753414B1 Novel use of peptide compounds for treating dyskinesia
12/28/2011	EP1443920B1 Preparation for improving the action of receptors
12/28/2011	EP1414456B1 Phenyl derivatives as factor xa inhibitors
12/28/2011	CN202086811U 一种用于治疗精神病及神经官能症的外用药袋 A treatment for psychosis and neurosis for topical Irazu
12/28/2011	CN1869051B 一种三醇组人参皂苷和二醇组人参皂苷的制备方法 Preparation method of PTS ginsenosides and diol group ginsenosides
12/28/2011	CN102300863A 具有乙基和乙烯基连接体的异唑/邻-吡啶衍生物 With ethyl and vinyl isobutyl linkers oxazole / o - pyridine derivative
12/28/2011	CN102300860A 作为磷酸二酯酶10抑制剂的吡嗪类化合物 As a phosphodiesterase inhibitor compound 10 pyrazines
12/28/2011	CN102300858A N-{[(1r,4s,6r)-3-(2-吡啶基羰基)-3-氮杂双环[4.1.0]庚-4-基]甲基}-2-杂芳基胺衍生物及其用途 N - {[(1r, 4s, 6r) -3- (2- pyridylcarbonyl) -3-azabicyclo [4.1.0] hept-4-yl] methyl} -2 heteroaryl amine derivative and their use
12/28/2011	CN102300857A N-{[(1r,4s,6r)-3-(2-吡啶基羰基)-3-氮杂双环[4.1.0]庚-4-基]甲基}-2-杂芳基胺衍生物及其用途 N - {[(1r, 4s, 6r) -3- (2- pyridylcarbonyl) -3-azabicyclo [4.1.0] hept-4-yl] methyl} -2 heteroaryl amine derivative and their use
12/28/2011	CN102300582A 用于治疗阿尔茨海默病的化合物和方法 Compounds and methods for the treatment of Alzheimer's disease
12/28/2011	CN102300579A 用于提供神经保护作用和认知增强的、包含油棕酚类物质的组合物 Used to provide neuroprotection and cognitive enhancement, the composition of phenolic compounds containing oil palm
12/28/2011	CN102300577A 羧甲基精氨酸生成抑制剂和胶原变性抑制剂 Carboxymethyl-arginine production inhibitors and inhibitors of collagen denaturation
12/28/2011	CN102300574A 新的吲哚基-二唑基-二氮杂二环壬烷衍生物及它们的医药和诊断用途 New indolyl - oxadiazolyl - diaza-bicyclo-nonane derivatives and their pharmaceutical and diagnostic purposes
12/28/2011	CN102300573A [2.2.2]双环衍生物及其使用方法 [2.2.2] bicyclic derivatives and methods of use

1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 ... 1833